4//SEC Filing
Johnson Anne Nagengast 4
Accession 0001140361-25-010113
CIK 0001840904other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 9:00 PM ET
Size
4.5 KB
Accession
0001140361-25-010113
Insider Transaction Report
Form 4
Johnson Anne Nagengast
Chief Financial Officer
Transactions
- Sale
Common Shares
2025-03-21$1.35/sh−33,545$45,286→ 140,045 total
Footnotes (1)
- [F1]Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units.
Documents
Issuer
ATAI Life Sciences N.V.
CIK 0001840904
Entity typeother
Related Parties
1- filerCIK 0001976640
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 9:00 PM ET
- Size
- 4.5 KB